Tioconazole Topical Side Effects
Medically reviewed by Drugs.com. Last updated on Dec 13, 2023.
Applies to tioconazole topical: intravaginal ointment.
Side effects include:
Vulvovaginal burning, irritation, vaginitis, pruritus, headache.
For healthcare professionals
Applies to tioconazole topical: vaginal ointment w/applicator.
Other adverse events
Topical solution:
Dermatologic
Topical solution:
- Uncommon (0.1% to 1%): Rash, dermatitis
- Frequency not reported: Bullous eruption, contact dermatitis, dry skin, nail disorder (including nail discoloration, periungual inflammation, nail pain), pruritus, skin irritation, skin exfoliation, urticaria[Ref]
Local
Topical solution:
- Frequency not reported: Local irritation (including local allergic reactions)
Vaginal ointment:
Topical solution: Local irritation (including local allergic reactions) usually occurred during the first week of therapy and was transient and mild.[Ref]
Genitourinary
Vaginal ointment:
- Frequency not reported: Increased vaginal burning, increased vaginal itching, increased vaginal irritation, vaginal swelling/redness, difficulty/burning on urination[Ref]
Gastrointestinal
Vaginal ointment:
- Frequency not reported: Abdominal pain/cramping[Ref]
Hypersensitivity
Topical solution:
- Frequency not reported: Allergic reaction
Other formulations than the dermatological preparation:
- Frequency not reported: Anaphylactoid reactions[Ref]
Nervous system
Topical solution:
- Frequency not reported: Paresthesia
Vaginal ointment:
- Frequency not reported: Headache[Ref]
Ocular
Topical solution:
- Frequency not reported: Periorbital edema[Ref]
Respiratory
Vaginal ointment:
- Frequency not reported: Upper respiratory infection[Ref]
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Stein GE, Gurwith D, Mummaw N, Gurwith M (1986) "Single-dose tioconazole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis." Antimicrob Agents Chemother, 29, p. 969-71
3. Clissold SP, Heel RC (1986) "Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses." Drugs, 31, p. 29-51
4. (2022) "Product Information. Vagistat-1 (tioconazole topical)." Bristol-Myers Squibb
5. Onayemi O, Aldridge RD, Shaw S (1992) "Allergic contact dermatitis from tioconazole. A report of 2 cases." Contact Dermatitis, 26, p. 193-4
6. Stubb S, Heikkila H, Reitamo S, Forstrom L (1992) "Contact allergy to tioconazole." Contact Dermatitis, 26, p. 155-8
7. Izu R, Aguirre A, Gonzalez M, Diaz-Perez JL (1992) "Contact dermatitis from tioconazole with cross-sensitivity to other imidazoles." Contact Dermatitis, 26, p. 130-1
8. Jones SK, Kennedy CT (1990) "Contact dermatitis from tioconazole." Contact Dermatitis, 22, p. 122-3
9. Gibson G, Buckley A, Murphy GM (1994) "Allergic contact dermatitis from tioconazole without cross- sensitivity to other imidazoles." Contact Dermatitis, 30, p. 308
10. Quirino AP, Barros MA (1994) "Contact dermatitis from tioconazole." Contact Dermatitis, 30, p. 240-1
11. Piletta P, Pasche-Koo F, Saurat JH (1993) "Contact dermatitis from tioconazole mimicking "one hand two feet syndrome"." Contact Dermatitis, 28, p. 308
12. Marren P, Powell S (1992) "Contact sensitivity to tioconazole and other imidazoles." Contact Dermatitis, 27, p. 129-30
13. Brunelli D, Vincenzi C, Morelli R, Tosti A (1992) "Contact dermatitis from tioconazole." Contact Dermatitis, 27, p. 120
14. Faria A, Goncalo S, Goncalo M, Freitas C, Baptista PP (1996) "Allergic contact dermatitis from tioconazole." Contact Dermatitis, 35, p. 250-2
More about tioconazole topical
- Compare alternatives
- Pricing & coupons
- Reviews (1,696)
- Dosage information
- During pregnancy
- Drug class: vaginal anti-infectives
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Tioconazole topical side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.